All Stories

  1. In Vitro Antibacterial Activity of Propyl-Propane-Thiosulfinate and Propyl-Propane-Thiosulfonate Derived from Allium spp. against Gram-Negative and Gram-Positive Multidrug-Resistant Bacteria Isolated from Human Samples
  2. Escherichia coli y Klebsiella pneumoniae productores de betalactamasa de espectro extendido en infecciones de vías urinarias: evolución de la resistencia antibiótica y opciones terapéuticas
  3. Prevalence and genetic diversity of Trichomonas vaginalis in the general population of Granada and co-infections with Gardnerella vaginalis and Candida species
  4. Activity of Fosfomycin on Clinical Isolates of Campylobacter jejuni and Campylobacter coli of Enteric Origin
  5. Etiological and Resistance Profile of Bacteria Involved in Urinary Tract Infections in Young Children
  6. Presencia de Streptococcus bovis en muestras de orina de sujetos con síntomas de infección del aparato urinario
  7. Especies de levaduras aisladas en muestras de orina en un hospital regional de España
  8. Performances from the laboratory to improve the clinical use of cefepime
  9. Different presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study
  10. Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: A 7-year surveillance study
  11. Evaluation of the rapid RIDAQUICK Campylobacter® test in a general hospital
  12. Implementation of a Computerized Decision Support System to Improve the Appropriateness of Antibiotic Therapy Using Local Microbiologic Data
  13. Sysmex UF-1000i performance for screening yeasts in urine
  14. Infectious agents associated with schizophrenia: A meta-analysis
  15. Low intrathecal immune response of anti–EBNA-1 antibodies and EBV DNA from multiple sclerosis patients
  16. Editorial [Hot Topic: Protective or Damaging Immunity in Infection (Guest Editors: Jose Gutierrez and Antonio Sorlozano)]
  17. New Strategies and Patent Therapeutics in EBV-Associated Diseases
  18. Serological diagnosis of Chlamydia pneumoniae infection: limitations and perspectives
  19. Antibiotic resistance patterns of bacterial strains isolated from Periplaneta americana and Musca domestica in Tangier, Morocco
  20. Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production
  21. Detection of new mutations conferring resistance to linezolid in glycopeptide-intermediate susceptibility Staphylococcus hominis subspecies hominis circulating in an intensive care unit
  22. Antimicrobial Development in the Era of Emerging Resistance
  23. Activity of Daptomycin Against Multiresistant Clinical Isolates of Staphylococcus aureus and Streptococcus agalactiae
  24. Development and evaluation of a multiplex test for the detection of atypical bacterial DNA in community-acquired pneumonia during childhood
  25. Comparative Evaluation of Three Culture Methods for the Isolation of Mycobacteria from Clinical Samples
  26. Chlamydophila pneumoniae: desde su proteómica hasta la arteriosclerosis
  27. Emerging strategies in the diagnosis, prevention and treatment ofChlamydophila pneumoniaeinfections
  28. Análisis de la producción científica en un hospital general de especialidades
  29. Activityin vitro of twelve antibiotics against clinical isolates of extended-spectrum beta-lactamase producing Escherichia coli
  30. High presence of extended-spectrum β-lactamases and resistance to quinolones in clinical isolates of Escherichia coli
  31. A comparison of the activity of tigecycline against multiresistant clinical isolates of Staphylococcus aureus and Streptococcus agalactiae
  32. Contribution of a New Mutation in parE to Quinolone Resistance in Extended-Spectrum- -Lactamase-Producing Escherichia coli Isolates
  33. Meta-Analysis of Studies Analyzing the Relationship Between Bladder Cancer and Infection by Human Papillomavirus
  34. Activity of tigecycline against clinical isolates of Staphylococcus aureus and extended-spectrum β-lactamase-producing Escherichia coli in Granada, Spain
  35. Descripción de inmunógenos de Chlamydia pneumoniae reconocidos por el suero de sujetos con enfermedad arterial periférica
  36. In vitro activity of β-lactam and non–β-lactam antibiotics in extended-spectrum β-lactamase–producing clinical isolates of Escherichia coli
  37. Comparison of the SYBR Green and the hybridization probe format for real-time PCR detection of HHV-6
  38. Evaluation of two automated systems for detection of bacteriuria
  39. A positive association of peripheral arterial occlusive disease (PAD) andChlamydophila (Clamydia) pneumoniae
  40. Relationship between peripheral arterial occlusive disease (PAOD) and chronic Chlamydophila (Chlamydia) pneumoniae infection. A meta-analysis
  41. Acceptable performance of VITEK 2 system to detect extended-spectrum β-lactamases in clinical isolates of Escherichia coli: a comparative study of phenotypic commercial methods and NCCLS guidelines
  42. High incidence of extended-spectrum β-lactamases among outpatient clinical isolates of Escherichia coli: a phenotypic assessment of NCCLS guidelines and a commercial method
  43. La utilización del sistema público de salud por el personal sanitario
  44. Linezolide e infección del tracto urinario